SureTrader Nadex Advertisement PGUS
Home > Boards > US Listed > Biotechs >

Inovio Pharmaceuticals, Inc. (INO)

INO RSS Feed
Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: ubernano, TomP1
Search This Board: 
Last Post: 3/29/2017 1:47:58 AM - Followers: 406 - Board type: Free - Posts Today: 1

Logo: Inovio

www.inovio.com/

http://finance.yahoo.com/q/ks?s=INO

http://finance.aol.com/company/inovio-biomedical-corporation/ino/ase/institutional-ownership

F
ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE- http://www.youtube.com/watch?v=95yO6hFpbUM


Float: 97.65 M

Shares Outstanding: 127.26 M


Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
 
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014
May 13, 2014:  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis
http://finance.yahoo.com/news/inovio-pharmaceuticals-acquires-early-stage-080000624.html?.tsrc=applewf

May 23, 2014: Inovio Pharmaceuticals Announces 1 For 4 Reverse Split
http://finance.yahoo.com/news/inovio-pharmaceuticals-announces-1-4-080000629.html
1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.


Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



 
 



 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
INO
Current Price
Volume:
Bid Ask Day's Range
SureTrader
News News Alert: Statement of Changes in Beneficial Ownership (4) 03/28/2017 02:44:48 PM
PostSubject
#13518  Sticky Note 2016 VALUE DRIVERS & MILESTONES (2nd-Half of 2016 Dr_Thorfin 08/01/16 01:50:30 PM
#4698  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 08/02/13 01:15:33 PM
#13849   lol ubernano & radly - you guys are fireopal 03/29/17 01:47:58 AM
#13848   Lotsa shares in trust for Collins wife, himself, ubernano 03/28/17 03:00:04 PM
#13847   Not sure about that. These levels has been Halks1122 03/23/17 04:16:46 PM
#13846   It's not electroporation like Inovio uses but could ubernano 03/23/17 10:06:53 AM
#13845   POC stock. Headed back down. Looks like this radly 03/21/17 06:52:52 PM
#13844   We just saw some huge blocks get bought sd1992 03/20/17 10:47:28 AM
#13843   Thank you very much for the info. sudnwealth 03/17/17 07:49:55 PM
#13842   INOH ON BREAKOUT ALERT FOR MONDAY big buys sd1992 03/17/17 03:59:23 PM
#13839   Inovio Pharmaceuticals Inc (NASDAQ:INO) was upgraded by analysts radly 03/16/17 08:55:04 PM
#13838   An easy google. kpisme 03/16/17 02:10:23 PM
#13837   Does anyone have access to the Piper Jaffrey sudnwealth 03/16/17 01:43:42 PM
#13836   Correction. Mid to low teens for most price Perkin78 03/14/17 03:53:16 PM
#13834   Call me dumb but what does this have radly 03/08/17 06:29:20 PM
#13833   MACIVIVA = Game Changer Trend-Setter 03/08/17 01:14:38 PM
#13832   I share ubernano's enthusiasm. Truly. But $100/share is Perkin78 03/06/17 01:58:11 PM
#13831   Not for me, I'm already in! ubernano 03/04/17 03:36:12 PM
#13830   Good for you and bravo for long term avav1001 03/04/17 01:50:46 PM
#13829   I bought INO at $1. ubernano 03/01/17 12:35:36 PM
#13828   Inovio (INO) hasn't accomplished a single product in MiamiGent 03/01/17 09:46:18 AM
#13827   Look, what is a cure for cancer, a ubernano 03/01/17 09:26:51 AM
#13826   Good luck with that. Really don't believe you radly 02/28/17 05:17:07 PM
#13825  Restored I'm 81 and I can wait forever for INO. ubernano 02/28/17 02:58:08 PM
#13824  Restored Good luck with that. I don't have 10 radly 02/28/17 02:54:28 PM
#13823   And then sell? ubernano 02/28/17 02:49:46 PM
#13822   Before a serious phase 2, a drug will Adi2 02/28/17 02:34:48 PM
#13821   Cancer drugs chances of clearing phase 3 from Adi2 02/28/17 02:29:49 PM
#13820   Hell, this thing can't even get back to $10 radly 02/28/17 01:55:36 PM
#13819   Definitely has $100 potential. ubernano 02/27/17 07:51:50 PM
#13818   If it sounds too good to be true, arvitar 02/27/17 10:00:12 AM
#13817   UNIVERSAL CANCER IMMUNOTHERAPY ubernano 02/27/17 09:15:19 AM
#13816   It has the potential, but we do not TomP1 02/27/17 09:14:02 AM
#13815   Is this latest announcement as big a deal desarcmo 02/27/17 09:00:30 AM
#13814   Inovio’s SynCon® WT1 Cancer Antigen Breaks Tolerance, Highlights TomP1 02/27/17 07:50:53 AM
#13813   The results of 3112 look very promising since AnonymousInvestor 02/26/17 06:10:41 PM
#13812   Positive news and the SP goes down. Of course! radly 02/24/17 08:08:06 PM
#13810   Inovio Reports New Positive Clinical Data on Vaccine TomP1 02/23/17 08:20:49 AM
#13809   China - the future by ApolloBio ubernano 02/13/17 01:56:00 PM
#13808  Restored This INO - ApolloBio deal could be what ubernano 02/13/17 12:41:22 PM
#13807   ApolloBio Corporation ubernano 02/13/17 09:18:21 AM
#13806   GANGBUSTERS! I'm raising my quite conservative $100 estimate for ubernano 02/13/17 09:06:00 AM
#13805   This is also 15 million for a very desarcmo 02/13/17 08:57:12 AM
#13804  Restored $15 million. Can somebody please tell MiamiGent to 7Bullet7 02/13/17 07:49:46 AM
#13803   Excellent! When is the FDA to lift this pre-clinical TomP1 02/13/17 07:07:30 AM
#13802   Inovio and ApolloBio to Collaborate on Development and lasers 02/13/17 06:54:31 AM
#13801   INO takes money and delivers health. ubernano 02/03/17 10:09:36 AM
#13800   All that taxpayer money and INO has nothing MiamiGent 02/02/17 10:43:29 PM
#13799   Dr. Kim says Inovio has received a total ubernano 02/02/17 12:52:47 PM
#13798   INO, Sanofi & tiny GOVX: Zika science leaders.Link remind2 02/02/17 10:03:08 AM
#13797   INO is not for everybody. ubernano 01/26/17 10:42:39 AM
#13795  Restored I believe in making America great. ubernano 01/26/17 09:52:19 AM
PostSubject